(-)-Vorozole

CAS No. 132042-69-4

(-)-Vorozole( —— )

Catalog No. M34141 CAS No. 132042-69-4

(-)-Vorozole is an orally active non-steroidal aromatase inhibitor with potency and selectivity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 172 In Stock
10MG 254 In Stock
25MG 392 In Stock
50MG 531 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (-)-Vorozole
  • Note
    Research use only, not for human use.
  • Brief Description
    (-)-Vorozole is an orally active non-steroidal aromatase inhibitor with potency and selectivity.
  • Description
    (-)-Vorozole is an orally active non-steroidal aromatase inhibitor with potency and selectivity. (-)-Vorozole has demonstrated antitumor activity in in vivo experiments. (-)-Vorozole is used in the study of breast cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    P450 | Aromatase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    132042-69-4
  • Formula Weight
    324.77
  • Molecular Formula
    C16H13ClN6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@H](C=1C=C2C(=CC1)N=NN2C)(C3=CC=C(Cl)C=C3)N4C=NC=N4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Omeprazole Sodium

    Omeprazole Sodium is a proton pump inhibitor(PPI) and suppresses gastric acid secretion. Omeprazole Sodium is a potent neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor).

  • Pradefovir mesylate

    Pradefovir mesylate is converted to 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in human liver microsomes with Km of 60 μM.

  • Anemosapogenin

    Anemosapogenin shows potent anti-tumor effect in vivo, but it has some toxicity, structure modification should be needed.